Anti-inflammatory effects of a triple-bond resveratrol analog: Structure and function relationship

European Journal of Pharmacology

Volumn 748, Issue , 2015, Pages 61-67

  Antus, Csenge ^a   Radnai, Balazs ^a   Dombovari, Peter ^a   Fonai, Fruzsina ^a   Avar, Peter ^a   Matyus, Peter ^b   Racz, Boglarka ^a   Sumegi, Balazs ^a,c   Veres, Balazs ^a  

^a UNIVERSITY OF PÉCS   (Hungary)

^b SEMMELWEIS UNIVERSITY   (Hungary)

^c UNIVERSITY OF PÉCS   (Hungary)

Author keywords

Inflammation; Lipopolysaccharide; Macrophage; NF kappaB

Indexed keywords

3,4',5 TRIHYDROXY DIPHENYLACETYLENE; CYCLOOXYGENASE 2; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; MITOGEN ACTIVATED PROTEIN KINASE P38; RESVERATROL; STRESS ACTIVATED PROTEIN KINASE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; 3,4',5-TRIHYDROXYDIPHENYLACETYLENE; ACETYLENE; ANTIINFLAMMATORY AGENT; ANTIOXIDANT; CYTOKINE; RESORCINOL DERIVATIVE; STILBENE DERIVATIVE;

ANIMAL CELL; ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; ARTICLE; CELL MEMBRANE DEPOLARIZATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; MACROPHAGE; MITOCHONDRIAL MEMBRANE; MOUSE; NONHUMAN; STRUCTURE ACTIVITY RELATION; ANALOGS AND DERIVATIVES; ANIMAL; BIOSYNTHESIS; CELL LINE; CELL SURVIVAL; CHEMISTRY; CYTOLOGY; DRUG EFFECTS; METABOLISM; MITOCHONDRIAL MEMBRANE POTENTIAL; SIGNAL TRANSDUCTION;

ACETYLENE; ANIMALS; ANTI-INFLAMMATORY AGENTS; ANTIOXIDANTS; CELL LINE; CELL SURVIVAL; CYTOKINES; LIPOPOLYSACCHARIDES; MACROPHAGES; MEMBRANE POTENTIAL, MITOCHONDRIAL; MICE; NF-KAPPA B; RESORCINOLS; SIGNAL TRANSDUCTION; STILBENES; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 84920187663     PISSN: 00142999     EISSN: 18790712     Source Type: Journal    
DOI: 10.1016/j.ejphar.2014.12.009     Document Type: Article

References (37)

1. J.S. Arthur, and S.C. Ley Mitogen-activated protein kinases in innate immunity Nat. Rev. Immunol. 13 2013 679 692
2. K. Ashikawa, S. Majumdar, S. Banerjee, A.C. Bharti, S. Shishodia, and B.B. Aggarwal Piceatannol inhibits TNF-induced NF-kappaB activation and NF-kappaB-mediated gene expression through suppression of IkappaBalpha kinase and p65 phosphorylation J. Immunol. 169 2002 6490 6497
3. R.L. Baehner, L.A. Boxer, and J. Davis The biochemical basis of nitroblue tetrazolium reduction in normal human and chronic granulomatous disease polymorphonuclear leukocytes Blood 48 1997 309 313
4. Y. Bai, Q.Q. Mao, J. Qin, X.Y. Zheng, Y.B. Wang, K. Yang, H.F. Shen, and L.P. Xie Resveratrol induces apoptosis and cell cycle arrest of human T24 bladder cancer cells in vitro and inhibits tumor growth in vivo Cancer Sci. 101 2010 488 493
5. M.V. Clément, J.L. Hirpara, S.H. Chawdhury, and S. Pervaiz Chemopreventive agent resveratrol, a natural product derived from grapes, triggers CD95 signaling-dependent apoptosis in human tumor cells Blood 92 1998 996 1002
6. M. Dave, M. Attur, G. Palmer, H.E. Al-Mussawir, L. Kennish, J. Patel, and S.B. Abramson The antioxidant resveratrol protects against chondrocyte apoptosis via effects on mitochondrial polarization and ATP production Arthritis Rheumatol. 58 2008 2786 2797
7. Docherty J., Tsai C., 2002. Methods for treating subjects infected with a herpes virus or neisseria gonorrheae. World patent WO 02/13764.
8. R.G. Faragher, D.G. Burton, P. Majecha, N.S. Fong, T. Davis, A. Sheerin, and E.L. Ostler Resveratrol, but not dihydroresveratrol, induces premature senescence in primary human fibroblasts Age 33 2011 555 564
9. B. Fauconneau, P. Waffo-Teguo, F. Huguet, L. Barrier, A. Decendit, and J.M. Merillon Comparative study of radical scavenger and antioxidant properties of phenolic compounds from Vitis vinifera cell cultures using in vitro tests Life Sci. 61 1997 2103 2110
10. M. Fontecave, M. Lepoivre, E. Elleingand, C. Gerez, and O. Guittet Resveratrol, a remarkable inhibitor of ribonucleotide reductase FEBS Lett. 421 1998 277 279
11. E.H. Heiss, Y.D. Schilder, and V.M. Dirsch Chronic treatment with resveratrol induces redox stress- and ataxia telangiectasia-mutated (ATM)-dependent senescence in p53-positive cancer cells J. Biol. Chem. 282 2007 26759 26766
12. J.J. Heynekamp, W.M. Weber, L.A. Hunsaker, A.M. Gonzales, R.A. Orlando, L.M. Deck, and D.L. Jagt Substituted trans-stilbenes, including analogues of the natural product resveratrol, inhibit the human tumor necrosis factor alpha-induced activation of transcription factor nuclear factor kappaB J. Med. Chem. 49 2006 7182 7189
13. P.B. Jakus, N. Kalman, C. Antus, B. Radnai, Z. Tucsek, F. Gallyas Jr, B. Sumegi, and B. Veres TRAF6 is functional in inhibition of TLR4-mediated NF-κB activation by resveratrol J. Nutr. Biochem. 24 2013 819 823
14. M. Jang, L. Cai, G.O. Udeani, K.V. Slowing, C.F. Thomas, C.W. Beecher, H.H. Fong, N.R. Farnsworth, A.D. Kinghorn, R.G. Mehta, R.C. Moon, and J.M. Pezzuto Cancer chemopreventive activity of resveratrol, a natural product derived from grapes Science 275 1997 218 220
15. S.S. Kang, M. Cuendet, D.C. Endringer, V.L. Croy, J.M. Pezzuto, and M.A. Lipton Synthesis and biological evaluation of a library of resveratrol analogues as inhibitors of COX-1, COX-2 and NF-kappaB Bioorg. Med. Chem. 17 2009 1044 1054
16. Y. Kimura, H. Okuda, and S. Arichi Effects of stilbenes on arachidonate metabolism in leukocytes Biochim. Biophys. Acta 834 1985 275 278
17. T. Kobayashi, Y. Ogawa, Y. Watanabe, M. Furuya, S. Kataoka, E.G. del Saz, S. Tsunawaki, M.C. Dinauer, and H. Seguchi Mitochondrial transmembrane potential is diminished in phorbol myristate acetate-stimulated peritoneal resident macrophages isolated from wild-type mice, but not in those from gp91-phox-deficient mice Histochem. Cell Biol. 122 2004 323 332
18. J.K. Kundu, and Y.J. Surh Cancer chemopreventive and therapeutic potential of resveratrol: mechanistic perspectives Cancer Lett. 269 2008 243 261
19. R. Lu, and G. Serrero Resveratrol, a natural product derived from grape, exhibits antiestrogenic activity and inhibits the growth of human breast cancer cells J. Cell Physiol. 179 1999 297 304
20. A.R. Martín, I. Villegas, M. Sánchez-Hidalgo, and C.A. de la Lastra The effects of resveratrol, a phytoalexin derived from red wines, on chronic inflammation induced in an experimentally induced colitis model Br. J. Pharmacol. 147 2006 873 885
21. K. Mizutani, K. Ikeda, Y. Kawai, and Y. Yamori Extract of wine phenolics improves aortic biomechanical properties in stroke-prone spontaneously hypertensive rats (SHRSP) J. Nutr. Sci. Vitaminol. 45 1999 95 106
22. G. Montsko, M.P. Nikfardjam, Z. Szabo, K. Boddi, T. Lorand, R. Ohmacht, and L. Mark Determination of products derived from trans-resveratrol UV photoisomerisation by means of HPLC-APCI-MS J. Photochem. Photobiol. A 196 2008 44 50
23. M. Murias, W. Jäger, N. Handler, T. Erker, Z. Horvath, T. Szekeres, H. Nohl, and L. Gille Antioxidant, prooxidant and cytotoxic activity of hydroxylated resveratrol analogues: structure-activity relationship Biochem. Pharmacol. 69 2005 903 912
24. F. Orallo Comparative studies of the antioxidant effects of cis- and trans-resveratrol Curr. Med. Chem. 13 2006 87 98
25. C.R. Pace-Asciak, S. Hahn, E.P. Diamandis, G. Soleas, and D.M. Goldberg The red wine phenolics trans-resveratrol and quercetin block human platelet aggregation and eicosanoid synthesis: implications for protection against coronary heart disease Clin. Chim. Acta 235 1995 207 219
26. C. Rius, M. Abu-Taha, C. Hermenegildo, L. Piqueras, J.M. Cerda-Nicolas, A.C. Issekutz, L. Estan, J. Cortijo, E.J. Morcillo, F. Orallo, and M.J. Sanz Trans- but not cis-resveratrol impairs angiotensin-II-mediated vascular inflammation through inhibition of NF-κB activation and peroxisome proliferator-activated receptor-gamma upregulation J. Immunol. 185 2010 3718 3727
27. P.A. Scherle, E.A. Jones, M.F. Favata, A.J. Daulerio, M.B. Covington, S.A. Nurnberg, R.L. Magolda, and J.M. Trzaskos Inhibition of MAP kinase kinase prevents cytokine and prostaglandin E2 production in lipopolysaccharide-stimulated monocytes J. Immunol. 161 1998 5681 5686
28. Q.B. She, A.M. Bode, W.Y. Ma, N.Y. Chen, and Z. Dong Resveratrol-induced activation of p53 and apoptosis is mediated by extracellular-signal-regulated protein kinases and p38 kinase Cancer Res. 61 2001 1604 1610
29. Q.B. She, C. Huang, Y. Zhang, and Z. Dong Involvement of c-jun NH(2)-terminal kinases in resveratrol-induced activation of p53 and apoptosis Mol. Carcinog. 33 2002 244 250
30. G.J. Soleas, E.P. Diamandis, and D.M. Goldberg Wine as a biological fluid: history, production, and role in disease prevention J. Clin. Lab. Anal. 11 1997 287 313
31. J.R. Stewart, and C.A. O'Brian Resveratrol antagonizes EGFR-dependent Erk1/2 activation in human androgen-independent prostate cancer cells with associated isozyme-selective PKC alpha inhibition Investig. New Drugs 22 2004 107 117
32. L.A. Stivala, M. Savio, F. Carafoli, P. Perucca, L. Bianchi, G. Maga, L. Forti, U.M. Pagnoni, A. Albini, E. Prosperi, and V. Vannini Specific structural determinants are responsible for the antioxidant activity and the cell cycle effects of resveratrol J. Biol. Chem. 276 2001 22586 22594
33. F.Y. Tang, E.P. Chiang, and Y.C. Sun Resveratrol inhibits heregulin-beta1-mediated matrix metalloproteinase-9 expression and cell invasion in human breast cancer cells J. Nutr. Biochem. 19 2008 287 294
34. S.H. Tsai, S.Y. Lin-Shiau, and J.K. Lin Suppression of nitric oxide synthase and the down-regulation of the activation of NFkappaB in macrophages by resveratrol Br. J. Pharmacol. 126 1999 673 680
35. Z. Tucsek, B. Radnai, B. Racz, B. Debreceni, J.K. Priber, T. Dolowschiak, T. Palkovics, F. Gallyas Jr, B. Sumegi, and B. Veres Suppressing LPS-induced early signal transduction in macrophages by a polyphenol degradation product: a critical role of MKP-1 J. Leukoc. Biol. 89 2011 105 111
36. G. Vairo, A.K. Royston, and J.A. Hamilton Biochemical events accompanying macrophage activation and the inhibition of colony-stimulating factor-1-induced macrophage proliferation by tumor necrosis factor-alpha, interferon-gamma, and lipopolysaccharide J. Cell Physiol. 151 1992 630 641
37. A.A. van de Loosdrecht, E. Nennie, G.J. Ossenkoppele, R.H. Beelen, and M.M. Langenhuijsen Cell mediated cytotoxicity against U937 cells by human monocytes and macrophages in a modified colorimetric MTT assay J. Immunol. Methods 141 1991 15 22